Dear Colleagues,
We are happy to invite you to the 8th meeting of Pharmacometrics Network
Benelux.
Please mark the following date and time in your agenda:
When: Thursday, April 14th 2015 – 12:00 – 18:00
Where: hosted by KU Leuven, Belgium (Justus Lipsiuszaal at Faculteit Letteren)
Blijde Inkomststraat, 21
3000 Leuven
For information on parking, you can click this link:
http://www.leuven.be/leven/mobiliteit-openbare-werken/parkeren/parkings/
Agenda theme: “Biomarkers or Clinical Endpoints? Or Both ?”
Registration: you can register by sending an e-mail to
[email protected]<mailto:[email protected]>
There is no registration fee, but registration is required for participation.
You can register until April 8th.
Scientific Program
12.00 – 13.00: Light lunch
13.00 – 13.15: Welcome
13.15 – 13.45: Graphical evaluation of pharmacometrics models for discrete
data
Jan-Stefaan van der Walt, Astellas (Netherlands)
13.45 – 14.15: Early readouts in clinical trials as predictors of the
future: some considerations and a case study in Hepatitis C
Filip de Ridder, Janssen (Belgium)
14.15 – 14.45: A semi-mechanistic comparator PKP model for intravenous
immunoglobulin (IVIG) provided mechanistic insights and supported a Go/No-go
decision for novel IVIG
Jos Lommers, Quantitative Solutions (Netherlands)
14.45 – 15.30: Coffee/Tea Break
15.30 – 16.00: Biomarkers and clinical endpoint: a regulatory perspective
Flora Musuamba, Federal Agency for Medicines and
Health Products (Belgium)
16.00 – 16.30: Student session
Evaluation of human gastrointestinal transfer by
PBPK modeling (in vivo-in silico approach)
Bart Hens, KUL (Belgium)
16.30 – 18.00: Closure followed by reception
We hope to see you in Leuven on April 14th !
Pieter Annaert
Anne Brochot
Eugène Cox
Thomas Kerbush
Charlotte van Kesteren
Ron Mathôt
Stefaan Rossenu
Laura Sargentini
Jan-Stefan van der Walt
On Pharmacometrics Network Benelux: the initiative aims to connect
pharmacometricians in the Benelux (Belgium, Netherlands, and Luxembourg). The
intention is to create an informal platform for the pharmacometrics community
in this region of the world (in industry, academia, hospital pharmacies as well
as regulatory bodies), with the goal to promote professional and scientific
awareness and interactions.
Stay tuned on our latest activity by joining our group on LinkedIn:
https://www.linkedin.com/grp/home?gid=4720442.
________________________________________
THIS E-MAIL MESSAGE IS INTENDED ONLY FOR THE USE OF THE INDIVIDUAL OR ENTITY TO
WHICH IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED,
CONFIDENTIAL AND EXEMPT FROM DISCLOSURE.
If the reader of this E-mail message is not the intended recipient, you are
hereby notified that any dissemination, distribution or copying of this
communication is strictly prohibited. If you have received this communication
in error, please notify us immediately at [email protected]. Thank you for your
co-operation.
"NANOBODY" and "NANOCLONE" are registered trademarks of Ablynx N.V.
________________________________________